Andera Partners | WebDisclosure

Basculer en Français

11118	Companies
244805	Keywords
172884	Articles
131993	Press releases

Home
Companies
Andera Partners

PRESS RELEASE

published on 10/22/2025 at 09:00, 11 months 12 days ago

Ipsen to acquire ImCheck Therapeutics, in Andera Partners’ portfolio, expanding its leadership in oncology, strengthening its pipeline
Ipsen to acquire ImCheck Therapeutics, expanding its leadership in oncology by acquiring all shares of ImCheck. Anticipated acquisition focuses on ICT01 program for acute myeloid leukemia. Transaction details and advisors highlighted

Acquisition Oncology Ipsen ImCheck Therapeutics ICT01
BRIEF

published on 10/16/2025 at 11:10, 11 months 18 days ago

Andera Partners co-dirige une levée de fonds de série A de 105 millions d'euros pour Adcytherix

Investissement Andera Partners Traitements Contre Le Cancer Adcytherix BioDiscovery 7
BRIEF

published on 10/16/2025 at 11:10, 11 months 18 days ago

Andera Partners Co-Leads €105 Million Series A for Adcytherix

Investment Andera Partners Cancer Treatments Adcytherix BioDiscovery 7
PRESS RELEASE

published on 10/16/2025 at 11:05, 11 months 18 days ago

Andera Partners co-leads €105 million Series A round for Adcytherix, its first investment from the BioDiscovery 7 fund
Andera Partners co-leads €105 million Series A funding round for Adcytherix, marking the first investment from BioDiscovery 7 fund to advance novel ADC programs for cancer treatment

Andera Partners ADC Series A Adcytherix BioDiscovery 7
BRIEF

published on 10/15/2025 at 11:15, 11 months 19 days ago

Andera Partners Commits to Tubulis' €308 Million Series C for ADC Development

Series C Financing Andera Partners Tubulis ADC Development Clinical Expansion
BRIEF

published on 10/15/2025 at 11:15, 11 months 19 days ago

Andera Partners s'engage dans la série C de Tubulis, d'un montant de 308 millions d'euros, pour le développement d'ADC

Andera Partners Tubulis Développement ADC Financement De Série C Expansion Clinique
PRESS RELEASE

published on 10/15/2025 at 11:10, 11 months 19 days ago

Andera Partners Reinvests in Tubulis’ €308 million Series C to Accelerate Clinical Development of Lead ADC Candidate TUB-040 and Expand Pipeline
Andera Partners reinvests in Tubulis' €308 million Series C financing to accelerate clinical development of lead ADC candidate TUB-040 and expand pipeline, attracting top-tier investors

Series C Financing Clinical Development Andera Partners Tubulis ADC Candidate
BRIEF

published on 06/12/2025 at 10:05, 1 year 3 months ago

Andera Partners Expands Mezzanine Sponsorless Strategy with Key Appointments

Andera Partners Strategic Appointments European Markets International Development Mezzanine Sponsorless
BRIEF

published on 06/12/2025 at 10:05, 1 year 3 months ago

Andera Partners élargit sa stratégie de financement mezzanine sans sponsor avec des nominations clés

Développement International Andera Partners Marchés Européens Nominations Stratégiques Mezzanine Sans Sponsor
PRESS RELEASE

published on 06/12/2025 at 10:00, 1 year 3 months ago

Andera Partners increases international development of its Mezzanine Sponsorless business and announces two strategic appointments
Andera Partners expands Mezzanine Sponsorless business internationally with two strategic appointments, reinforcing European private financing strategy

Andera Partners Strategic Appointments International Development Mezzanine Sponsorless Private Financing

Accesswire

Published on 10/03/2026 at 02:35, 17 hours 17 minutes ago

Jaguar Health Announces a Special Stock Dividend
Published on 10/02/2026 at 17:45, 1 day 2 hours ago

Sparton Provides Status Update
Published on 10/02/2026 at 13:50, 1 day 6 hours ago

AI/ML Innovations Appoints Lynn Chapman as Chief Financial Officer and Announces Share Issuance for Debt Settlement
Published on 10/02/2026 at 13:00, 1 day 6 hours ago

Evergold Drills 4.9 m of 7.70 g/t Au and 186.0 g/t Ag Within 13.5 Metres of 2.84 g/t Au and 127.6 g/t Ag in First 2026 Drill Holes at Golden Lion
Published on 10/02/2026 at 13:00, 1 day 6 hours ago

Alaska Energy Metals Appoints Independent Director, Thomas Benson

View all ACCESSWIRE

EQS Group

Published on 10/03/2026 at 15:45, 4 hours 7 minutes ago

Huawei Highlights Continuous Innovation, Securing Competitive Edge Through Technological Breakthroughs
Published on 10/02/2026 at 23:55, 19 hours 57 minutes ago

IS SKINCARE GETTING TOO COMPLICATED? CERAVE MAKES THE CASE FOR SAFETY, EFFICACY AND SIMPLICITY
Published on 10/02/2026 at 20:23, 23 hours 29 minutes ago

EQS-Adhoc: Pentixapharm Holding AG: Bafin concludes financial reporting review of the 2024 consolidated financial statements with an error finding
Published on 10/02/2026 at 19:46, 1 day ago

innoscripta SE: Update on the Tax Authorities’ Investigation – Business Operations Continue as Usual – Full Transparency Assured – Invitation to Shareholders for an In-Person Product Presentation
Published on 10/02/2026 at 19:00, 1 day ago

INFORMATIONS RELATIVES AU NOMBRE TOTAL DE DROITS DE VOTE ET AU NOMBRE D’ACTIONS COMPOSANT LE CAPITAL SOCIAL AU TITRE DE L’ARTICLE 223-16 DU REGLEMENT GENERAL DE L'AMF

Les Echos

Published on 10/02/2026 at 17:45, 1 day 2 hours ago

Information concerning the total number of voting rights and shares 2026 09 30
Published on 10/02/2026 at 17:45, 1 day 2 hours ago

Informations relatives au nombre total de droits de vote et d’actions 2026 09 30
Published on 10/02/2026 at 17:35, 1 day 2 hours ago

Peugeot Invest - Déclaration du nombre d'actions et de droits de vote
Published on 10/02/2026 at 17:30, 1 day 2 hours ago

Aéroports de Paris SA - 2027 Financial Calendar
Published on 10/02/2026 at 17:30, 1 day 2 hours ago

Aéroports de Paris SA - Calendrier financier 2027

View all LES ECHOS COMFI WIRE